Contact us

Meiogenix develops proprietary breeding technologies based on targeted recombination — a precise, natural process that unlocks genetic diversity in crops and accelerates the development of elite varieties.

Conventional breeding is limited by regions of the genome that are inaccessible, slowing genetic gain. Targeted recombination directs natural chromosome swaps at specific sites, enabling access to traits and combinations that traditional methods can’t reach.

Unlike GMOs, our approach does not introduce foreign DNA. And unlike gene editing, targeted recombination allows breeders to access natural diversity and separate desirable traits from unwanted ones, all with a simpler regulatory path.

We’ve achieved proof of concept in rice, tomato, and corn, and our technology is being applied to other major crops like soybean and wheat, with potential across many plant species.

Our technology accelerates breeding timelines, unlocks complex traits like disease resistance and drought tolerance, and reduces the land, time, and resources needed to develop resilient varieties.

By improving efficiency in breeding and enabling climate-resilient traits, we help reduce inputs, strengthen biodiversity, and support long-term global food security.

We collaborate through licensing agreements, joint developments, and strategic partnerships with global seed leaders and NGOs. Our business model includes license fees, milestones, and royalties, creating value for both Meiogenix and our partners.

Our work is supported by more than 30 patents across key markets, and was recently published in Frontiers in Plant Science (Herbert et al., 2025), showing a threefold increase in recombination in rice compared to controls.

To become a global leader in accelerating genetic gain and advanced variety development — with our technology in every breeder’s toolkit, transforming agriculture worldwide.